identified cholesterol esterification enzyme (ACAT1) as a metabolic checkpoint that regulates tumor immune response, and inhibition of its activity can increase the level of free cholesterol on CD8+ T cell membrane, thereby enhancing the tumor-killing ability of CD8+ T cells (81). This evidence concerns the gene CD8A and neoplasm.